Navigation Links
Decriminalizing pot may land more kids in the ER

WASHINGTON States that decriminalized marijuana saw dramatic increases in children requiring medical intervention, although the overall number of unintentional marijuana exposures among children remained low. The Annals of Emergency Medicine study of call volume to U.S. poison centers from January 2005 through December 2011 will be published online today ("Association of Unintentional Pediatric Exposures with Decriminalization of Marijuana in the U.S.").

"We believe that high-dose edible products such as candies, cookies and chocolates may have played a significant role in the increased rate of reported exposure chiefly because kids can't distinguish between products that contain marijuana and those that don't," said lead study author George Sam Wang, MD, of the Rocky Mountain Poison and Drug Center in Denver, Colo. "These edible products may be attractive to children and tend to contain higher concentrations of the active ingredient, tetrahydrocannabinol."

The call rate to poison centers in states that decriminalized marijuana increased by more than 30 percent per year between 2005 and 2011, while the call rate in non-legal states did not change. More pediatric exposures in decriminalized states than in non-legal states required medical evaluation, had moderate to major clinical effects and required critical care admissions. Neurologic effects were the most common. The most common therapy was administration of intravenous fluids. Aggressive interventions were rare and there were no deaths.

As of December 2013, 18 states and the District of Columbia had passed legislation allowing medical marijuana, which includes many edible products. Sales are projected to more than double between 2011 and 2015.

"Pediatricians, toxicologists and emergency physicians need to be willing to advocate for the safety of children to lawmakers as this burgeoning industry expands across the U.S.," said Dr. Wang. "As more states decriminalize marijuana, lawmakers should consider requirements such as child-resistant packaging, warning labels and public education to reduce the likelihood of ingestion by young children."


Contact: Julie Lloyd
American College of Emergency Physicians

Post Your Comments:
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: ) ... provide their customers enhanced security to access and ...
(Date:4/15/2016)... , April 15, 2016  A new partnership ... more accurate underwriting decisions in a fraction of ... competitively priced and high-value life insurance policies to ... With Force Diagnostics, rapid testing (A1C, ... data readings (blood pressure, weight, pulse, BMI, and ...
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the leading software as ... Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio and video ... trial team. , Using the CONSULT module, patients and physicians can schedule a face ...
(Date:6/27/2016)... , June 27, 2016   Ginkgo Bioworks ... to industrial engineering, was today awarded as one ... selection of the world,s most innovative companies. Ginkgo ... scale for the real world in the nutrition, ... engineers work directly with customers including Fortune 500 ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
Breaking Biology Technology: